REFERENCES
- Bailar, J. C. 1967. Thromboembolism and oestrogen therapy. Lancet II, 560.
- Bailar, J. C. & Byar, D. P. 1970. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer 26, 257.
- Byar, D. P. 1972. Treatment of prostatic cancer: Studies by the Veterans Co-operative Urological Research Group. Bull N Y Acad Med 48, 751.
- Carlson, L. A. 1960. Serum lipids in men with myocardial infarction. Acta Med Scand 167, 399.
- Editorials. 1970. Oestrogens in the pill. Lancet I, 929.
- Editorials. 1973. Carcinoma of the prostate. Br Med J II, 566.
- Furman, R. H., Alaupovic, P., Bradford, R. H. & Howard, R. P. 1968. Gonadal hormones, blood lipids and ischemic heart disease. Progr Biochem Pharmacol 4, 334.
- Hanash, K. A., Taylor, W. F. & Greene, L. F. 1970. Relationship of estrogen therapy for carcinoma of the prostate to atherosclerotic cardiovascular disease: a clinicopathologic study. J Urol 103, 467.
- Herbst, W. P. 1941. The effects of estradiol dipro-pionate and diethylstilboestrol on malignant prostatis tissue. Trans Am Assoc Genitourin Surg 34, 195.
- Huggins, C. & Hodges, C. V. 1941. Studies on prostatic cancer. 1. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1. 293.
- Jönsson, G. 1972. Hormonbehandling av cancer prostate. In Hormoner och hormonterapi (ed. U.Borell) p. 253. Wezäta. Göteborg.
- Kannel, W. B., Dawbler, T. R., Friedman, G. D., Glennon, W. E. & McNamara, P. M. 1964. Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease. Ann Intern Med 61, 888.
- Kessler, G. & Lederer, H. 1966. Fluorometric measurement of triglycerides. In Automation in analytical chemistry (ed. L. T.Skeggs), p. 341. Mediad, New York.
- Kontturi, M. & Sotaniemi, E. 1970. Estrogen induced metabolic changes during treatment of prostatic cancer. Scand J Clin Lab Invest 25, 45 (suppl.) 113.
- Kontturi, M. & Sotaniemi, E. 1971a. Thromboembolism during estrogen therapy of prostatic cancer. Report of two cases. Scand J Urol Nephrol 5, 108.
- Kontturi, M. & Sotaniemi, E. 1971b. Effect of estrogen on the serum cholesterol and triglyceride levels of prostatic cancer patients. J Urol 105, 847.
- Kontturi, M. J., Sotaniemi, E. A. & Larmi, T. K. I. 1974. Body fluid and electrolyte balance during estrogen therapy of prostatic cancer J Urol III, 652.
- Levine, J., Morgenstern, S. & Vlastelica, D. 1967. A direct Liebermann-Burchard method for serum cholesterol. Automation in analytical chemistry. Technicon Symposium, Oct 2, New York.
- Oliver, M. F. & Boyd, G. S. 1961. Influence of reduction of serum lipids on prognosis of coronary heart disease. A five-year study using estrogens. Lancet II, 499.
- Russ, E. M., Howard, A. E. & Barr, D. P. 1955. Influence of gonadal hormones on protein-lipid relationships in human plasma. Am J Med 19, 4.
- Shahmanesh, M., Bolton, C. H., Feneley, R. C. L. & Hartog, M. 1973. Metabolic effects of estrogen treatment in patients with carcinoma of prostate: A comparison of stilbestrol and conjugated equine estrogens. Br Med J II, 512.
- Veterans Administration Co-operative Urological Research Group. 1967. Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obst 124, 1011.